Evidence map›Paper›PMID 33395989›Full record

ArticleNeuroImage. Clinical2020

Progressive multifocal leukoencephalopathy lesion and brain parenchymal segmentation from MRI using serial deep convolutional neural networks.

Omar Al-Louzi, Snehashis Roy, Ikesinachi Osuorah, Prasanna Parvathaneni, Bryan R Smith, Joan Ohayon, Pascal Sati, Dzung L Pham, Steven Jacobson, Avindra Nath and 2 more

Open access · goldAbstract read
In one paragraph

Article in NeuroImage. Clinical, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. A Novel Convolutional Neural Network for Automated Multiple Sclerosis Brain Lesion Segmentation.Journal of neuroimaging : official journal of the American Society of Neuroimaging
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Omar Al-LouziTranslational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA; Neuroimmunology Clinic, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.
Snehashis RoySection of Neural Function, National Institute of Mental Health, Bethesda, MD, USA.
Ikesinachi OsuorahNeuroimmunology Clinic, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.
Prasanna ParvathaneniTranslational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.
Bryan R SmithSection of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.
Joan OhayonNeuroimmunology Clinic, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.
Pascal SatiTranslational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA; Department of Neurology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Dzung L PhamCenter for Neuroscience and Regenerative Medicine, The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.
Steven JacobsonViral Immunology Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.
Avindra NathSection of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.
Daniel S ReichTranslational Neuroradiology Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA; Neuroimmunology Clinic, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.
Irene CorteseNeuroimmunology Clinic, National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA. Electronic address: corteseir@ninds.nih.gov.
National Institute of Neurological Disorders and Stroke · USCedars-Sinai Medical Center · USHenry M. Jackson Foundation · USNational Institute of Mental Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Progressive multifocal leukoencephalopathy (PML) is a rare opportunistic brain infection caused by the JC virus and associated with substantial morbidity and mortality. Accurate MRI assessment of PML lesion burden and brain parenchymal atrophy is of decisive value in monitoring the disease course and response to therapy. However, there are currently no validated automatic methods for quantification of PML lesion burden or associated parenchymal volume loss. Furthermore, manual brain or lesion delineations can be tedious, require the use of valuable time resources by radiologists or trained experts, and are often subjective. In this work, we introduce JCnet (named after the causative viral agent), an end-to-end, fully automated method for brain parenchymal and lesion segmentation in PML using consecutive 3D patch-based convolutional neural networks. The network architecture consists of multi-view feature pyramid networks with hierarchical residual learning blocks containing embedded batch normalization and nonlinear activation functions. The feature maps across the bottom-up and top-down pathways of the feature pyramids are merged, and an output probability membership generated through convolutional pathways, thus rendering the method fully convolutional. Our results show that this approach outperforms and improves longitudinal consistency compared to conventional, state-of-the-art methods of healthy brain and multiple sclerosis lesion segmentation, utilized here as comparators given the lack of available methods validated for use in PML. The ability to produce robust and accurate automated measures of brain atrophy and lesion segmentation in PML is not only valuable clinically but holds promise toward including standardized quantitative MRI measures in clinical trials of targeted therapies. Code is available at: https://github.com/omarallouz/JCnet.

Indexed as

Deep LearningLeukoencephalopathy, Progressive MultifocalBrainHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingNeural Networks, ComputerBrain parenchymal fractionConvolutional neural networksDeep learningLesion segmentationMagnetic resonance imagingProgressive multifocal leukoencephalopathy

Identifiers

PMID33395989
PMCPMC7708929
OpenAlexW3104877382

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.